Vinpocetine

4 studies read · 1 answers · 2 sources

Vinpocetine does not have enough research to establish dependable improvements in thinking or brain blood flow, with only early, single-study signals supporting either outcome.

What it does

Early findings (1)
  • Clearer, quicker thinking · Unclear if it helps

    1 review of 4 trials · 837 people · noticed in 12 weeks

How to take it

Vinpocetine is not a strong first choice if you want a well-established supplement for focus or memory. The reviewed human evidence includes only early, single-study signals for brain blood flow and everyday thinking, not a dependable cognitive benefit.1 Avoid it during pregnancy or when trying to conceive because of serious fetal safety concerns.2

How much

For brain blood flow and oxygen delivery, research examined oral doses of 10-30 mg, with 20 mg as the median effective dose in the reviewed study.1 A separate study of steadier everyday thinking examined 30-60 mg orally, but it did not show a statistically significant result.1 These are research doses, not an established personal dosing standard.

When

The reviewed studies used oral vinpocetine as a daily intervention, not as an occasional pre-work or pre-study supplement.1 No reliable human evidence identifies a best time of day, or shows that taking it with food versus without food changes cognitive results. Do not treat it like a stimulant with a proven same-day focus effect.1

Which form

Look for a product that lists vinpocetine itself in milligrams. The relevant research concerns oral vinpocetine, not lesser-periwinkle tea, whole-plant powder, or vague "periwinkle extract" labels.1 A botanical source on a label does not make those products interchangeable.

The dose that worked, by measure (1)
Improve brain blood flow and oxygen delivery
20 mg

Who should be careful

Medicines it can clash with

  • digoxin major
  • indinavir major
  • warfarin major
  • tolbutamide moderate
  • omeprazole minor
  • dextromethorphan minor
  • chlorzoxazone minor

Reported side effects

  • fetal death severe
  • post-implantation loss severe
  • abortion severe
  • ventricular septum defect severe
  • decreased fetal weight moderate
  • supernumerary ribs moderate
  • delayed ossification moderate
  • abnormal vaginal discharge moderate

Bottles worth buying

Dosed where the research is, in a clean formula, from audited brands. Not sponsored.

How it works

Vinpocetine gets marketed as a brain booster, but the human evidence is much thinner than the hype.1

Vinpocetine is a semi-synthetic compound based on vincamine, an alkaloid from lesser periwinkle. It is sold as a cognitive supplement, although the small reviewed human evidence base has focused more on brain blood flow than on proven day-to-day mental performance.1

Vinpocetine slows phosphodiesterase 1, an enzyme that clears chemical signals inside cells. Think of it as partially closing a drain, so some brain-cell signals remain in the sink longer.1 Laboratory research also shows activity at sodium channels and inflammatory signaling, but those biological effects do not establish sharper thinking in people.1

Common questions

Does vinpocetine improve memory or focus?

It is too early to say. Single human studies have examined broader everyday thinking and brain blood flow, but the reviewed evidence does not establish a reliable improvement in memory, focus, or overall cognition.1

Is vinpocetine safe during pregnancy?

No. The FDA warns that vinpocetine can harm fetal development and advises women who are pregnant or could become pregnant not to use it.2

Is vinpocetine the same as periwinkle extract?

No. Vinpocetine is a semi-synthetic compound based on vincamine, a natural alkaloid found in lesser periwinkle. A whole-plant periwinkle product is not interchangeable with vinpocetine used in research.1

Sources

  1. 1. Vinpocetine: a review of its pharmacological properties and clinical efficacy in the treatment of cerebrovascular disorders  (2003)
  2. 2. FDA warns that vinpocetine in dietary supplements may be unsafe for women of childbearing age  (2019)